Leading the Way in Life Science Technologies

GEN Exclusives

More »
Readers Comments Back to Item »

The Global Outlook for Regenerative Medicine and Stem Cells

1 Readers' Comments

Posted by: Editor: http//stemcelldigest.net

08/25/2009

The stem cell sector we cover, consisting of twenty companies all traded on U.S. exchanges, has shown the ability to raise capital even in the difficult environment of the last twelve months. I agree about the patent issue and the confusion that abounds there. Legal and regulatory harmonization is probably a long way off and will follow rather than lead the development of applicable therapies.

  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »